Rosuvastatin Affecting Aortic Valve Endothelium

CompletedOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

September 30, 2003

Study Completion Date

May 31, 2005

Conditions
AtherosclerosisHypercholesterolemia
Interventions
DRUG

Rosuvastatin

Trial Locations (1)

Unknown

Hospital Pedro Hispano, Porto

All Listed Sponsors
collaborator

Northwestern University

OTHER

lead

Hospital Pedro Hispano

OTHER

NCT00114491 - Rosuvastatin Affecting Aortic Valve Endothelium | Biotech Hunter | Biotech Hunter